You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DF4

Showing 1 - 25 of 3,211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ventricular Arrythmia, Lead, ICD Trial in Lisbon, Alicante, Girona (INVICTA lead)

Active, not recruiting
  • Ventricular Arrythmia
  • +3 more
  • INVICTA lead
  • Lisbon, Portugal
  • +2 more
Nov 30, 2022

Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

Enrolling by invitation
  • Hiv
  • Weight Gain
  • Toronto, Ontario, Canada
    University Health Network
May 17, 2022

Osteoporosis, Postmenopausal Trial in Stoke (Jumping exercise, Balance exercise (sham control))

Terminated
  • Osteoporosis, Postmenopausal
  • Jumping exercise
  • Balance exercise (sham control)
  • Stoke, England, United Kingdom
    Staffordshire University
Sep 21, 2021

Type2Diabetes, Severe Mental Disorder Trial in London

Recruiting
  • Type2Diabetes
  • Severe Mental Disorder
    • London, United Kingdom
    • +8 more
    Jul 11, 2022

    Type 2 Diabetes, Severe Mental Disorder Trial in London (Diabetes specialist nurse-led collaborative care intervention)

    Not yet recruiting
    • Type 2 Diabetes
    • Severe Mental Disorder
    • Diabetes specialist nurse-led collaborative care intervention
    • London, United Kingdom
    • +8 more
    Aug 9, 2022

    Stage 4 Chronic Kidney Disease Trial in Mexico City (ketoanalogues of essential amino acids)

    Completed
    • Stage 4 Chronic Kidney Disease
    • ketoanalogues of essential amino acids
    • Mexico City, DF, Mexico
    • +1 more
    Aug 6, 2021

    Dengue Trial in Brazil (Dengue 1,2,3,4 (attenuated) vaccine, Placebo)

    Active, not recruiting
    • Dengue
    • Dengue 1,2,3,4 (attenuated) vaccine
    • Placebo
    • Manaus, Amazonas, Brazil
    • +16 more
    Jan 16, 2023

    People With Diabetes: A Quantitative Diagnostic Approach

    Suspended
    • Diabetes
    • +3 more
    • Observation
    • Stoke-on-Trent, Staffordshire, United Kingdom
      Staffordshire University
    Jan 19, 2021

    Implantable Defibrillator User Trial in United States

    Terminated
    Has Results
    • Implantable Defibrillator User
      • Gadsden, Alabama
      • +67 more
      Jun 8, 2020

      AMP SCZ® Observational Study: PREDICT-DPACC

      Recruiting
      • Clinical High Risk
      • +3 more
        • Irvine, California
        • +41 more
        Jun 6, 2023

        Coronavirus Disease 2019 Previously Enrolled inRO7496998 Study

        Completed
        • COVID-19
        • Long COVID
          • Mar Del Plata, Argentina
          • +44 more
          Apr 15, 2022

          Ventricular Arrythmia, Lead, ICD Trial in Worldwide (Implant of the INVICTA lead)

          Unknown status
          • Ventricular Arrythmia
          • +3 more
          • Implant of the INVICTA lead
          • Brest, France
          • +9 more
          Apr 15, 2019

          Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)

          Recruiting
          • Relapsed or Refractory Multiple Myeloma
          • Berkeley, California
          • +188 more
          Jan 27, 2023

          Pulmonary Hypertension Trial in Worldwide (Sildenafil citrate)

          Completed
          • Pulmonary Hypertension
          • Sildenafil citrate
          • Birmingham, Alabama
          • +64 more
          Jan 28, 2021

          Epilepsy Trial in Worldwide (Ezogabine: USAN Retigabine (International Nonproprietary Name))

          Completed
          Has Results
          • Epilepsy
          • Ezogabine: USAN Retigabine (International Nonproprietary Name)
          • Birmingham, Alabama
          • +50 more
          Jul 14, 2020

          Hypertension, Hypercholesterolemia Trial in Worldwide (Amlodipine besylate/atorvastatin calcium single pill combination)

          Completed
          Has Results
          • Hypertension
          • Hypercholesterolemia
          • Amlodipine besylate/atorvastatin calcium single pill combination
          • Desamparados, San Jose, Costa Rica
          • +125 more
          Jan 26, 2021

          Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

          Recruiting
          • Multiple Sclerosis, Primary Progressive
          • Scottsdale, Arizona
          • +197 more
          Jan 2, 2023

          Leukemia Trial in Worldwide (Dasatinib)

          Active, not recruiting
          Has Results
          • Leukemia
          • Birmingham, Alabama
          • +173 more
          Dec 1, 2022

          COVID-19 Trial in Worldwide (RO7496998, Placebo)

          Terminated
          • COVID-19
          • Cordoba, Argentina
          • +96 more
          Jan 21, 2022

          Solid Tumor, Adult Trial in Providence, Nashville (DF6215)

          Not yet recruiting
          • Solid Tumor, Adult
          • Providence, Rhode Island
          • +1 more
          Oct 25, 2023

          Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

          Recruiting
          • Relapsing-Remitting Multiple Sclerosis
          • La Jolla, California
          • +66 more
          Jan 27, 2023

          COVID-19 Trial in Worldwide (RO7496998, Placebo)

          Suspended
          • COVID-19
          • Cordoba, Argentina
          • +95 more
          Nov 17, 2021

          Arthritis, Gouty Trial in Worldwide (Indomethacin, Celecoxib)

          Completed
          Has Results
          • Arthritis, Gouty
          • Glendale, Arizona
          • +80 more
          Feb 18, 2021

          Healthy, Safety and Tolerability Trial in Cypress (DF-003, Placebo)

          Recruiting
          • Healthy
          • Safety and Tolerability
          • Cypress, California
            Altasciences Clinical Los Angeles, Inc
          Aug 9, 2023

          Osteoporosis Trial in Worldwide (ALX1-11 (drug))

          Completed
          • Osteoporosis
          • ALX1-11 (drug)
          • Birmingham, Alabama
          • +131 more
          May 13, 2021